Ionis Pharmaceuticals Inc (NAS:IONS)
$ 35.91 -0.42 (-1.16%) Market Cap: 5.74 Bil Enterprise Value: 4.73 Bil PE Ratio: 0 PB Ratio: 8.65 GF Score: 40/100

Ionis Pharmaceuticals Inc at RBC Capital Markets Global Healthcare Conference Transcript

May 16, 2023 / 02:00PM GMT
Release Date Price: $35.99 (-0.69%)
Luca Issi
RBC Capital Markets, Research Division - Research Analyst

Luca Issi, senior biotech analyst here at RBC Capital Markets. And today is a great privilege to have Ionis with a fireside chat. Representing the company, we have Brett Monia, Chief Executive Officer.

Brett, thanks so much for joining us. How are you doing today?

Brett P. Monia
Ionis Pharmaceuticals, Inc. - Founder, CEO & Director

I'm doing great. Thanks, Luca. It's really, really great to be here, and thanks for the opportunity.

Questions & Answers

Luca Issi
RBC Capital Markets, Research Division - Research Analyst

Fantastic. We have a long list of questions here, but maybe before I ask you about the individual programs, can you just talk big picture about what progress has the organization made over the last few months? And maybe most importantly, what's ahead here for Ionis?

Brett P. Monia
Ionis Pharmaceuticals, Inc. - Founder, CEO & Director

Sure. Happy to. So I think

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot